Evaluation and Prognostic Relevance of Right Ventricular–Arterial Coupling in Pulmonary Hypertension

Manuel J. Richter(Justus-Liebig-Universität Gießen), Khodr Tello(Universities of Giessen and Marburg Lung Center), Dana C. Peters(Justus-Liebig-Universität Gießen), Henning Gall(German Center for Lung Research), Natascha Sommer(Cardio-Pulmonary Institute), Fritz Roller(Justus-Liebig-Universität Gießen), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Robert Naeije(Erasmus Hospital), Werner Seeger(Justus-Liebig-Universität Gießen)
American Journal of Respiratory and Critical Care Medicine
September 20, 2019
10.1164/rccm.201906-1195le
Cited by 136

Related Papers

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
|The Lancet|2013|1.5k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k